We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health, Inc. (OSCR) Advances While Market Declines: Some Information for Investors
Read MoreHide Full Article
Oscar Health, Inc. (OSCR - Free Report) ended the recent trading session at $32.91, demonstrating a +1.76% change from the preceding day's closing price. This change outpaced the S&P 500's 0.22% loss on the day. Meanwhile, the Dow experienced a drop of 0.66%, and the technology-dominated Nasdaq saw a decrease of 0.22%.
Prior to today's trading, shares of the company had lost 2.03% was narrower than the Finance sector's loss of 4.09% and lagged the S&P 500's gain of 1.4%.
Analysts and investors alike will be keeping a close eye on the performance of Oscar Health, Inc. in its upcoming earnings disclosure. The company is expected to report EPS of -$0.11, up 79.25% from the prior-year quarter. In the meantime, our current consensus estimate forecasts the revenue to be $4.72 billion, indicating a 58.14% growth compared to the corresponding quarter of the prior year.
For the full year, the Zacks Consensus Estimates project earnings of $1.83 per share and a revenue of $18.81 billion, demonstrating changes of +208.28% and +60.77%, respectively, from the preceding year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Oscar Health, Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 18.79% higher. Oscar Health, Inc. is holding a Zacks Rank of #1 (Strong Buy) right now.
In terms of valuation, Oscar Health, Inc. is presently being traded at a Forward P/E ratio of 17.64. This signifies a premium in comparison to the average Forward P/E of 9.84 for its industry.
It is also worth noting that OSCR currently has a PEG ratio of 0.35. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Insurance - Multi line was holding an average PEG ratio of 0.92 at yesterday's closing price.
The Insurance - Multi line industry is part of the Finance sector. This industry currently has a Zacks Industry Rank of 107, which puts it in the top 44% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
View the Zacks #1 Rank List
Image: Bigstock
Oscar Health, Inc. (OSCR) Advances While Market Declines: Some Information for Investors
Oscar Health, Inc. (OSCR - Free Report) ended the recent trading session at $32.91, demonstrating a +1.76% change from the preceding day's closing price. This change outpaced the S&P 500's 0.22% loss on the day. Meanwhile, the Dow experienced a drop of 0.66%, and the technology-dominated Nasdaq saw a decrease of 0.22%.
Prior to today's trading, shares of the company had lost 2.03% was narrower than the Finance sector's loss of 4.09% and lagged the S&P 500's gain of 1.4%.
Analysts and investors alike will be keeping a close eye on the performance of Oscar Health, Inc. in its upcoming earnings disclosure. The company is expected to report EPS of -$0.11, up 79.25% from the prior-year quarter. In the meantime, our current consensus estimate forecasts the revenue to be $4.72 billion, indicating a 58.14% growth compared to the corresponding quarter of the prior year.
For the full year, the Zacks Consensus Estimates project earnings of $1.83 per share and a revenue of $18.81 billion, demonstrating changes of +208.28% and +60.77%, respectively, from the preceding year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Oscar Health, Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 18.79% higher. Oscar Health, Inc. is holding a Zacks Rank of #1 (Strong Buy) right now.
In terms of valuation, Oscar Health, Inc. is presently being traded at a Forward P/E ratio of 17.64. This signifies a premium in comparison to the average Forward P/E of 9.84 for its industry.
It is also worth noting that OSCR currently has a PEG ratio of 0.35. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Insurance - Multi line was holding an average PEG ratio of 0.92 at yesterday's closing price.
The Insurance - Multi line industry is part of the Finance sector. This industry currently has a Zacks Industry Rank of 107, which puts it in the top 44% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.